How Hemp Oil Interacts With Weight-Loss Medications
Use caution · The honest verdict
Worth a conversation with your clinician
Hemp seed oil has no documented pharmacokinetic interaction with semaglutide or tirzepatide, but its antiplatelet effects at higher doses warrant caution with anticoagulants, and the common consumer confusion between hemp oil and CBD oil is clinically meaningful.
Hemp oil, specifically cold-pressed hemp seed oil, is a nutritional oil rich in omega-6 and omega-3 fatty acids. It does not contain significant CBD or THC and has no established CYP450 drug interactions. The primary concerns for GLP-1 patients are a modest antiplatelet effect that can compound with blood thinners, and the frequent misidentification of CBD oil as hemp oil, which carries a different, more serious interaction profile.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Why they interact
Here's what actually happens when Hemp Oil meets Warfarin and antiplatelet drugs (additive bleeding risk from omega-3/omega-6 fatty-acid content at higher doses); no documented CYP450 interactions for hemp seed oil (distinguished from CBD oil, which inhibits CYP3A4 and CYP2C9 at therapeutic doses); no direct GLP-1 pharmacokinetic interaction; possible additive blood-pressure-lowering effect if on antihypertensives. — in plain language.
Hemp seed oil is extracted by cold-pressing seeds of Cannabis sativa L. and contains no significant tetrahydrocannabinol (THC) or cannabidiol (CBD)—the cannabinoids responsible for psychoactive effects and CYP450 drug interactions, respectively. Its fatty-acid profile is approximately 55–60% linoleic acid (LA, omega-6) and 15–20% alpha-linolenic acid (ALA, omega-3), yielding an omega-6:omega-3 ratio of approximately 3:1. The oil also contains gamma-linolenic acid (GLA, ~3–4%), which has anti-inflammatory properties. The key mechanistic concerns relevant to GLP-1 patients: (1) Antiplatelet effect—like other polyunsaturated fatty-acid-rich oils, hemp seed oil at supplement doses may modestly inhibit thromboxane A2 synthesis and platelet aggregation, particularly relevant for patients on warfarin, aspirin, or other antiplatelets; this effect is weaker than fish oil EPA/DHA but is not absent. (2) GI tolerability—GLP-1 drugs delay gastric emptying; any supplemental oil taken at mealtime adds dietary fat, which further stimulates CCK-mediated gastric-emptying delay and may worsen nausea during dose-escalation weeks. (3) The CBD/hemp confusion: many patients searching 'hemp oil weight loss medication' are actually using CBD oil, which inhibits CYP3A4 and CYP2C9 and may affect co-medications metabolized by those enzymes. Hemp seed oil has no established CYP450 interactions.
What the research says
USDA FoodData Central for hemp seed oil fatty-acid composition; FDA CBD drug interaction guidance (Epidiolex labeling and safety communication, 2019) for CYP450 interactions relevant to CBD (not hemp seed oil); NIH ODS polyunsaturated fatty acids overview for antiplatelet mechanism; no direct hemp seed oil + semaglutide or tirzepatide co-administration studies; the omega-6:omega-3 ratio evidence base is population-epidemiology literature.
Does it depend on which GLP-1?
The picture can differ slightly across medications. Here's what to know for each.
Semaglutide (Ozempic, Wegovy)
No documented direct pharmacokinetic interaction; semaglutide is cleared by peptide cleavage, not CYP450 enzymes; hemp seed oil does not bind GLP-1 receptors or affect semaglutide bioavailability; anticoagulant co-medication concern is independent of semaglutide mechanism.
Tirzepatide (Mounjaro, Zepbound)
Same rationale as semaglutide; no pharmacokinetic interaction identified; anticoagulant concern applies equally.
When and how to take it
Take with a meal for fat-soluble nutrient absorption and to minimize GI upset; disclose to prescriber and pharmacist if on warfarin, aspirin, clopidogrel, or apixaban—monitor INR if anticoagulated; during GLP-1 dose-escalation weeks, reduce or hold oily supplements to minimize compounding of nausea; clearly distinguish hemp seed oil from CBD oil when discussing with healthcare providers—the drug-interaction profiles are different; if CBD oil is also being used, a separate interaction discussion with the prescriber is warranted.
Signs to watch for
- Prolonged bleeding from cuts, easy bruising, or elevated INR (antiplatelet effect compounding anticoagulants)
- Dizziness or lightheadedness if also on antihypertensives (possible additive blood-pressure lowering)
- Worsening nausea, bloating, or early satiety during GLP-1 dose escalation (dietary fat load)
- If also using CBD products: any sedation, dizziness, or unexpected medication effect amplification (CYP450 interaction—not hemp seed oil, but CBD)
What to do about it
Practical, non-prescriptive steps — the specifics still belong to you and your clinician.
Confirm the exact product: check the label for 'CBD' or 'cannabidiol' content; cold-pressed hemp seed oil will list only hemp seed oil as the ingredient.
Disclose all hemp-derived products to your prescriber, specifying whether it is seed oil or a CBD extract.
If using hemp seed oil, start with small culinary amounts (1 teaspoon) rather than tablespoon supplement doses, especially during the first 8 weeks of GLP-1 therapy.
If on warfarin or antiplatelet drugs, request an INR check within 2 weeks of starting hemp seed oil and monitor for unusual bruising or bleeding.
If you are actually using CBD oil, schedule a separate medication review with your pharmacist to screen for CYP450 interactions.
Hemp Seed Oil vs. CBD Oil—The Product Confusion That Changes Everything
The single most important question when a GLP-1 patient asks about 'hemp oil' is which product they actually have in their hand. The Cannabis sativa plant yields two completely different oils with completely different safety profiles, and the supplement industry has not made it easy to tell them apart.
Hemp seed oil is cold-pressed from the seeds of the hemp plant. It contains a nutritional fatty-acid profile—predominantly linoleic acid and alpha-linolenic acid—and negligible amounts of cannabinoids. It does not contain CBD at meaningful concentrations, and it does not interact with the cytochrome P450 enzyme system. CBD oil, by contrast, is extracted from the flowers, leaves, and stalks of the same plant using solvents or CO2. It contains cannabidiol at pharmacologically active concentrations, and the FDA has documented that CBD inhibits CYP3A4 and CYP2C9—the same liver enzymes that metabolize many common medications including certain statins, warfarin, and some blood pressure drugs.
The labeling problem is pervasive. Products labeled 'hemp oil' or 'hemp extract oil' on the front panel may be hemp seed oil, full-spectrum CBD oil, or broad-spectrum CBD oil. The only way to know is to read the supplement facts panel and ingredient list. Hemp seed oil will list 'hemp seed oil' as the sole ingredient. CBD products will list 'cannabidiol' or 'hemp extract' with a milligram amount per serving. If you are on a GLP-1 medication and using any hemp-derived product, identifying which one you have is the clinical step that determines whether you need a standard fatty-acid caution or a formal CYP450 drug-interaction review.
- Hemp seed oil: cold-pressed from seeds, no significant CBD or THC, no CYP450 interactions
- CBD oil: extracted from flowers/leaves, contains cannabidiol, inhibits CYP3A4 and CYP2C9
- Label check: look for 'cannabidiol' or mg amounts of CBD on the supplement facts panel
- If the ingredient list says only 'hemp seed oil,' you are holding a nutritional oil, not a CBD product
Bottom line
Hemp seed oil and CBD oil are different products from the same plant with completely different safety profiles—hemp seed oil has no documented CYP450 interactions, while CBD oil does; this distinction is the most clinically important question when a GLP-1 patient asks about 'hemp oil.'
Fatty-Acid Profile—What Hemp Seed Oil Actually Delivers
Hemp seed oil earns its reputation as a nutritionally favorable oil primarily because of its fatty-acid composition. The oil is roughly 55–60% linoleic acid (LA, an omega-6 fatty acid) and 15–20% alpha-linolenic acid (ALA, an omega-3 fatty acid), producing an omega-6-to-omega-3 ratio of approximately 3:1. That ratio is frequently cited as close to the ideal dietary balance, especially when compared to the typical Western diet, which often runs 15:1 or higher.
The oil also contains gamma-linolenic acid (GLA) at roughly 3–4%. GLA is an omega-6 fatty acid that follows a different metabolic pathway than linoleic acid—it converts to dihomo-gamma-linolenic acid (DGLA), which competes with arachidonic acid in prostaglandin synthesis and exerts a net anti-inflammatory signaling effect. This is distinct from the pro-inflammatory cascade typically associated with high omega-6 intake from processed vegetable oils.
What hemp seed oil does not provide is equally important. It contains no EPA (eicosapentaenoic acid) and no DHA (docosahexaenoic acid)—the long-chain omega-3 fatty acids with the strongest cardiovascular-outcome evidence. The human body can convert ALA to EPA and DHA, but the conversion rate is inefficient, typically under 5–10% for EPA and under 1% for DHA. For GLP-1 patients seeking the cardiovascular risk reduction associated with omega-3s, fish oil or algae-based EPA/DHA supplements remain the evidence standard. Hemp seed oil is a healthy culinary oil with a favorable fatty-acid ratio; it is not a substitute for EPA and DHA.
- Omega-6 (linoleic acid): ~55–60%
- Omega-3 (alpha-linolenic acid): ~15–20%
- Omega-6:omega-3 ratio: ~3:1 (favorable vs. typical Western diet)
- GLA (gamma-linolenic acid): ~3–4%, with anti-inflammatory signaling properties
- Contains zero EPA and zero DHA—the long-chain omega-3s with cardiovascular trial evidence
Bottom line
Hemp seed oil offers a nutritionally favorable fatty-acid ratio and anti-inflammatory GLA content, but it does not provide EPA or DHA—GLP-1 patients seeking omega-3 cardiovascular benefit need fish oil or algae-based EPA/DHA, not hemp seed oil alone.
Antiplatelet Properties and Anticoagulant Risk
Polyunsaturated fatty acids, including the linoleic acid and alpha-linolenic acid abundant in hemp seed oil, can modestly inhibit platelet aggregation. The mechanism involves partial suppression of thromboxane A2 synthesis, a pathway that aspirin targets more potently. At typical supplement doses of 1–3 tablespoons per day or equivalent capsule doses of 1,000–3,000 mg, hemp seed oil introduces a mild antiplatelet effect that is real but weaker than the EPA/DHA-driven effect of fish oil.
For most people, this antiplatelet activity is clinically insignificant. For patients on warfarin, however, even a modest additional inhibition of platelet function can elevate INR and increase bleeding risk. The same additive concern applies to patients on direct oral anticoagulants like apixaban or rivaroxaban, and to those on antiplatelet drugs including aspirin and clopidogrel. The standard precaution for fatty-acid supplements applies: disclose hemp seed oil use to your prescriber, monitor INR if you are on warfarin, and watch for signs of excessive bleeding such as easy bruising, prolonged bleeding from minor cuts, or blood in the stool.
This anticoagulant concern is entirely independent of GLP-1 receptor agonists. Semaglutide and tirzepatide do not affect platelet function or coagulation pathways in a way that compounds this risk. The interaction is between hemp seed oil and the anticoagulant or antiplatelet drug itself. If you are on a GLP-1 medication but not on any blood thinner, the antiplatelet effect of hemp seed oil at culinary or standard supplement doses is unlikely to cause a bleeding problem.
- Mechanism: polyunsaturated fats partially inhibit thromboxane A2 synthesis and platelet aggregation
- Relevant drugs: warfarin, apixaban, rivaroxaban, aspirin, clopidogrel
- Monitoring: check INR within 2 weeks of starting hemp seed oil if on warfarin
- This risk is independent of semaglutide or tirzepatide—it is an anticoagulant interaction, not a GLP-1 interaction
Bottom line
Hemp seed oil's antiplatelet effect is real but weaker than fish oil—it is not zero, and patients on warfarin or antiplatelet drugs should disclose hemp seed oil use and monitor INR; this concern is independent of the GLP-1 drug itself.
GI Tolerability During GLP-1 Dose Escalation
GLP-1 receptor agonists work in part by delaying gastric emptying—food stays in the stomach longer, which contributes to satiety but also to the nausea, bloating, and early fullness that are the most common side effects during the first 4–8 weeks of treatment. Dietary fat is a potent stimulator of cholecystokinin (CCK), a hormone that further slows gastric emptying. When you combine a GLP-1 drug's gastric-emptying delay with a high-fat meal or a concentrated oil supplement, you are stacking two mechanisms that slow stomach clearance.
Taking 1–3 tablespoons of hemp seed oil daily during the nausea-peak weeks of GLP-1 dose escalation is a common mistake that can amplify bloating and early satiety to an uncomfortable degree. The effect is not specific to hemp seed oil—any oil supplement, from olive oil to fish oil, can do the same thing. The practical distinction is dose and form. A teaspoon of hemp seed oil drizzled on a salad is a small dietary fat load that is unlikely to cause problems. A tablespoon swallowed straight from a spoon or multiple large capsules taken at once represents a concentrated fat bolus that lands in a stomach already slowed by medication.
The guidance is straightforward: during the first 4–8 weeks of GLP-1 therapy, and for 1–2 weeks after each dose increase, reduce or hold supplemental oil doses. Small culinary amounts used in food preparation are generally fine. Once your body has adapted to the medication and nausea has subsided, you can reintroduce supplement-dose oils gradually, watching for any return of GI symptoms.
- GLP-1 drugs delay gastric emptying; dietary fat stimulates CCK, compounding the delay
- Supplement doses (1–3 tbsp/day) during the first 4–8 weeks frequently worsen nausea and bloating
- Culinary doses (1 tsp in food) are much less likely to cause GI issues
- This is a class effect of all oils, not specific to hemp seed oil
- Reintroduce supplement doses gradually after GI adaptation to the GLP-1 medication
Bottom line
The form and dose matter—small culinary amounts of hemp seed oil are unlikely to worsen GLP-1 GI symptoms; supplemental tablespoon doses during dose-escalation weeks often do.
Practical Guidance—Disclosure, Labeling, and the CBD Question
The most important practical step for a GLP-1 patient using any hemp-derived product is to identify exactly what they have and communicate the distinction to their prescriber. Hemp seed oil requires standard fatty-acid caution: disclose to your doctor if you are on anticoagulants, monitor for bleeding signs, and be mindful of GI tolerability during dose escalation. CBD oil warrants a formal drug-interaction check because of its CYP450 inhibition profile.
Reading a hemp product label correctly is a skill worth developing. Look at the supplement facts panel, not the front-label marketing. A true hemp seed oil will list 'hemp seed oil' as the ingredient, with a fat breakdown (polyunsaturated, monounsaturated, saturated) in the nutrition panel. A CBD product will list 'cannabidiol' or 'hemp extract' with a specific milligram amount per serving—5 mg, 25 mg, 50 mg, and so on. The extraction method is another clue: 'cold-pressed' or 'expeller-pressed' indicates seed oil; 'CO2 extracted' or 'ethanol extracted' typically indicates a cannabinoid extract from flowers and leaves.
For hemp seed oil specifically, there is no established pharmacological dose for GLP-1 interaction prevention because no interaction exists to prevent. Typical culinary or supplement use is 1–2 tablespoons per day. If you choose to use it, refrigerate the bottle after opening—polyunsaturated oils oxidize and go rancid quickly at room temperature, typically within 6–8 weeks. A rancid oil not only tastes unpleasant but contains lipid peroxides that are pro-inflammatory, undoing the anti-inflammatory benefit you sought in the first place. If your hemp seed oil smells like crayons or old nuts, discard it.
If you are also using a CBD product alongside your GLP-1 medication, that is a separate conversation with your healthcare provider. CBD's inhibition of CYP3A4 and CYP2C9 can affect the metabolism of multiple drug classes, and the interaction potential is real. Do not assume that because hemp seed oil is safe, CBD oil is equally benign—they are different products with different pharmacology.
- Check the supplement facts panel: 'hemp seed oil' alone = nutritional oil; 'cannabidiol' with mg amount = CBD product
- Extraction method clue: cold-pressed = seed oil; CO2 or ethanol extracted = cannabinoid extract
- No established GLP-1-specific dose limit for hemp seed oil; 1–2 tbsp/day is typical culinary or supplement use
- Refrigerate after opening; discard if it smells rancid (usually within 6–8 weeks)
- If using CBD oil, schedule a separate pharmacist medication review—CYP450 interactions are a distinct concern
Bottom line
The most important practical step for a GLP-1 patient using 'hemp oil' is to identify exactly which product they have and communicate the distinction to their prescriber—hemp seed oil requires standard fatty-acid caution, while CBD oil warrants a formal drug-interaction check.
What most pages leave out
Most online content conflates hemp seed oil with CBD oil or overstates hemp oil's benefits without distinguishing product types. This page is honest that hemp seed oil has no documented GLP-1 pharmacokinetic interaction but makes the CBD distinction its clinical centerpiece—a genuinely practical gap in current supplement-interaction content.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
Hemp seed oil has no pharmacokinetic interaction with semaglutide. The main caution is a modest antiplatelet effect that matters if you are on blood thinners, and the potential for worsened nausea if you take large oil doses during the first weeks of treatment. Crucially, confirm whether you are using hemp seed oil or CBD oil—they have completely different interaction profiles.
The same rationale applies as with semaglutide. Hemp seed oil has no direct drug interaction with tirzepatide. The concerns are anticoagulant compounding if you are on blood thinners, and GI tolerability during dose escalation. If you are actually using CBD oil rather than hemp seed oil, a separate drug-interaction check is warranted.
Hemp seed oil has no documented pharmacokinetic interaction with GLP-1 weight-loss medications like semaglutide or tirzepatide. CBD oil, which is often confused with hemp seed oil, inhibits CYP3A4 and CYP2C9 and may affect how your body metabolizes other medications. Confirming which product you have is the essential first step.
Hemp seed oil has a modest antiplatelet effect from its polyunsaturated fat content that can add to warfarin's blood-thinning effect. Disclose your hemp seed oil use to your prescriber, monitor your INR within two weeks of starting, and watch for signs of excessive bleeding like easy bruising or prolonged bleeding from cuts.
It can, especially at supplement doses of 1–3 tablespoons per day. High-fat supplements slow gastric emptying further, compounding the effect that causes GLP-1 nausea. During the first 4–8 weeks of treatment and after each dose increase, stick to small culinary amounts like a teaspoon in food rather than tablespoon doses.
Hemp seed oil has no documented CYP450 enzyme interactions. CBD oil inhibits CYP3A4 and CYP2C9, which are liver enzymes that metabolize many common drugs including certain statins, warfarin, and some blood pressure medications. The products are frequently confused but have fundamentally different safety profiles.
There is no established weight-loss benefit from hemp seed oil at supplement doses. Its omega-6-to-omega-3 ratio is nutritionally favorable, and its GLA content has anti-inflammatory properties, but it does not supplement or enhance the weight-loss mechanism of GLP-1 drugs. It is a healthy culinary oil, not a weight-loss aid.
There is no GLP-1-specific pharmacokinetic dose limit for hemp seed oil. Standard culinary or supplement use of 1–2 tablespoons per day is generally fine for people not on blood thinners. Antiplatelet concerns increase with dose, so anyone on warfarin or antiplatelet drugs should disclose use and monitor accordingly. During GLP-1 dose escalation, smaller amounts are better tolerated.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
How Fish Oil / Omega-3 Fatty Acids Interacts With Weight Loss Medications
Fish oil has no direct drug interaction with semaglutide or tirzepatide, but GI upset and high-dose antiplatelet effects matter. A practical, honest guide.
Read moreHow Borage Oil Interacts with Weight-Loss Medications
Borage oil has no direct interaction with GLP-1 drugs, but its GLA content may increase bleeding risk with anticoagulants. Learn about PA contamination and safe use.
Read moreHow Flaxseed Oil Interacts with Weight-Loss Medications
Flaxseed oil has no direct interaction with GLP-1s, but its antiplatelet effect warrants caution with blood thinners. Learn why ALA isn't a substitute for fish oil.
Read moreHow CBD Oil (Cannabidiol) Interacts with Weight-Loss Medications
CBD doesn't directly interact with semaglutide or tirzepatide, but it potently inhibits CYP450 enzymes, affecting many common co-medications. Learn the real risks.
Read moreHow MCT Oil (Medium Chain Triglycerides) Interacts with Weight Loss Medications
MCT oil can worsen diarrhea and cramping from GLP-1 meds like semaglutide. Learn why the GI risks compound, and how to use it safely if you choose to.
Read moreHow Cod Liver Oil Interacts with Weight-Loss Medications
Cod liver oil has no direct interaction with GLP-1s, but its preformed vitamin A and D can silently stack to toxic levels with multivitamins. Learn the real risks.
Read moreOn a GLP-1, or thinking about one?
If you take Hemp Oil alongside a GLP-1, it helps to have your medication managed by a clinician who sees the whole picture.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
Important: This page is general information, not medical advice, and it does not account for your health or medications. Supplements can interact with prescription drugs in ways that depend on your dose and situation. Curex offers compounded GLP-1 medications through licensed clinicians — compounded medications are not FDA-approved, and the FDA has not evaluated their safety or efficacy. The supplement discussed here is not a Curex product. Always talk to your pharmacist or prescriber before combining a supplement with any weight-loss medication.
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.